Clinical trial Recruiting at 1 site Interventional Ages 4 to 11 Men only

Investigating genetic differences in twins with and without Down syndrome

Official title: Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome

Run by Institut Jerome Lejeune · NCT05767216 · Data updated 2026-11-12

This study is trying to understand the genetic differences between twins, one with Down syndrome and one without, to see how these differences might affect their health and development.

Quick facts

Study typeInterventional
Ages4 Years to 11 Years
SexMen only
Enrollment5 (estimated)
SponsorInstitut Jerome Lejeune
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedDecember 20, 2022
Main results expectedDecember 30, 2023
Study endsDecember 30, 2028
Registry record updatedMarch 14, 2023
Trial IDNCT05767216 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include heterokaryotypic monozygotic twins discordant for Down syndrome and age-matched dizygotic twins or patients with mosaic Down syndrome.

Probably not a fit

Patients who are not part of a heterokaryotypic monozygotic twin pair or do not have a genetic connection to Down syndrome may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on heterokaryotypic monozygotic twins who are discordant for Down syndrome, aiming to explore genetic and epigenetic variations between them. By conducting multi-omics analyses, researchers will assess how genomic changes affect protein expression and biochemical modifications, while also examining the influence of environmental factors. The study will generate induced pluripotent stem cells from the twins' blood and fibroblasts to create in-vitro models for further investigation into Down syndrome pathogenesis. Additionally, the human gut microbiome will be analyzed for its potential role in health and disease.

Why it matters

Potential benefit: If successful, this research could lead to new insights and therapeutic approaches for Down syndrome.

How similar studies have gone: While studies on twins and genetic variations exist, this specific approach focusing on heterokaryotypic monozygotic twins is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Twins of a heterokaryotypic monozygotic pair discordant for DS
* Twins of a sex- and class of age-matched dizygotic pair discordant for DS,
* Sex- and class of age-matched patient with mosaic T21
* Subject's parents/legal representatives willing to give written informed consent.
* Subject and his/her parents/legal representatives must be able/willing to comply with the protocol.
* Subject covered by social welfare.

Exclusion Criteria:

* None

Where it's running

  • Institut Jérôme Lejeune
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.